131
Views
3
CrossRef citations to date
0
Altmetric
Article

Repeated chemotherapy cycles produced progressively worse and enduring impairments in the sleep–wake profile of hospitalized breast cancer patients

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1166-1181 | Received 01 Dec 2018, Accepted 03 Dec 2018, Published online: 23 Dec 2018

References

  • Alfano CM, Lichstein KL, Vander-Wal GS, Smith AW, Reeve BB, McTiernan A, Bernstein L, Baumgartner KB, Ballard-Barbash R. 2011. Sleep duration change across breast cancer survivorship: associations with symptoms and health-related quality of life. Breast Cancer Res Treat. 130(1):243–254.
  • Ancoli Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale, Cohen-Zion M, Fiorentino L. 2006. Fatigue, sleep and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 14(3):201–209.
  • Ancoli Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J. 2014. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 22(9):2535–2545.
  • Ancoli-Israel S. 2015. Sleep disturbances in cancer: A review. Sleep Med Res. 6(2):45–49.
  • Ancoli-Israel S, Rissling M, Trofimenko V, Parker BA. 2007. Preliminary effects of bright light on sleep in women with breast cancer. J Clin Oncol ASCO Annual Meeting Proc Suppl. 25(18S):9094.
  • Aurell J, Elmquist D. 1985. Sleep in the surgical intensive care unit: continuous polygraphic recording in nine patients receiving postoperative care. Br Med J (Clin Res Ed). 290(6474):1029–1032.
  • Beck SL, Berger AM, Barsevick AM, Wong B, Stewart KA, Dudley WN. 2010. Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer. 18(6):679–689.
  • Berger AM. 1995. Activity/rest patterns and perceived fatigue and sleep quality during the first week of intravenous chemotherapy for early stage breast cancer. Oncol Nurs Forum. 22:A54.
  • Berger AM. 1998. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 25(1):51–62.
  • Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S. 2007. Values of sleep/wake, activity/ rest,circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage. 33(4):398–409.
  • Berger AM, Higginbotham P. 2000. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum. 27(9):1443–1448.
  • Berger AM, Wielgus KK, Young-McCaughan S, Fischer P, Farr L, Lee KA. 2008. Methodological challenges when using actigraphy in research. J Pain Symptom Manage. 36(2):191–199.
  • Bernhofer EI, Higgins PA, Daly BJ, Burant CJ, Hornick TR. 2014. Hospital lighting and its association with sleep, mood and pain in medical inpatients. J Adv Nurs. 70(5):1164–1173.
  • Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. 1989. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 28(2):193–213.
  • Chang WP, Lin CC. 2014. Correlation between rest-activity rhythm and survival in cancer patients experiencing pain. Chronobiol Int. 31(8):926–934.
  • Chen WY, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Schernhammer ES. 2014. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 145(2):381–388.
  • Courneya KS, Segal RJ, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Jespersen D, Cook D, Proulx C, et al. 2014. Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial. Breast Cancer Res Treat. 144(2):361–369.
  • Dhruva A, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Dunn LB, Swift PS, Wara W, Miaskowski C. 2012. A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manage. 44(2):215–228.
  • Espie CA, Fleming L, Cassidy J, Samuel L, Taylor LM, White CA, Douglas NJ, Engleman HM, Kelly HL, Paul J. 2008. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 26(28):4651–4658.
  • Hacker ED, Kapella MC, Park C, Ferrans CE, Larson JL. 2015. Sleep patterns during hospitalization following hematopoietic stem cell transplantation. Oncol Nurs Forum. 42(4):371–379.
  • Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. 2002. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 59(2):131–136.
  • Kuo HH, Chiu MJ, Liao WC, Hwang SL. 2006. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J Formos Med Assoc. 105(1):64–69.
  • Littner M, Kushida CA, Anderson WM, Bailey D, Berry RB, Davila DG, Hirshkowitz M, Kapen S, Kramer M, Loube D, et al. 2003. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 26(3):337–341.
  • Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S. 2009. Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue, and depression during chemotherapy. Psychooncology. 18(2):187–194.
  • Liu L, Fiorentino L, Rissling M, Natarajan L, Parker BA, Dimsdale JE, Mills PJ, Sadler GR, Ancoli-Israel S. 2013. Decreased health-related quality of life in women with breast cancer is associated with poor sleep. Behav Sleep Med. 11(3):189–206.
  • Lo-Fo-Wong DNN, de-Haes HCJM, Aaronson NK, van-Abbema DL, den-Boer MD, van-Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MBE, Reyners AKL, et al. 2016. Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Res Treat. 158:563–572.
  • Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E. 2012. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat. 132(3):1107–1118.
  • Madsen MT, Huang C, Gögenur I. 2015. Actigraphy for measurements of sleep in relation to oncological treatment of patients with cancer: a systematic review. Sleep Med Rev. 20:73–83.
  • Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE. 2017. Sleep duration and breast cancer prognosis: perspectives from the women’s healthy eating and living study. Breast Cancer Res Treat. 162(3):581–589.
  • Mills PJ, Parker BA, Jones V, Adler KA, Perez CJ, Johnson S, Cohen-Zion M, Marler M, Sadler GR, Dimsdale JE, et al. 2004. The effects of standard anthracycline-based chemotherapy on soluble icam-1 and VEFG levels in breast cancer. Clin Cancer Res. 10(15):4998–5003.
  • Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, et al. 2007. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 30(4):519–529.
  • Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, Davis SM, Morrison RS. 2001. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 29(2):277–282.
  • Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer H, Nouriani B, Spiegel D. 2014. Actigraphy measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep. 37(5):837–842.
  • Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. 2010. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester cancer center-community clinical oncology program. J Clin Oncol. 28(2):292–298.
  • Pati AK, Parganiha A, Kar A, Soni R, Roy S, Choudhary V. 2006. Implications of the study of rest-activity circadian rhythm in head and neck cancer patients. Biol Rhythm Res. 37(6):497–505.
  • Pati AK, Parganiha A, Kar A, Soni R, Roy S, Choudhary V. 2007. Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients. Chronobiol Int. 24(6):1179–1197.
  • Payne J, Piper B, Rabinowitz I, Zimmerman B. 2006. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum. 33(4):775–783.
  • Phipps AI, Bhatti P, Neuhouser ML, Chen C, Crane TE, Kroenke CH, Ochs-Balcom H, Rissling M, Snively BM, Stefanick ML, et al. 2016. Pre-diagnostic sleep duration and sleep quality in relation to subsequent cancer survival. J Clin Sleep Med. 12(4):495–503.
  • Sadeh A. 2011. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev. 15(4):259–267.
  • Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, et al. 2009. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 32(9):1155–1160.
  • Savard J, Simard S, Blanchet J, Ivers H, Morin CM. 2001. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 24(5):583–590.
  • Savard J, Simard S, Ivers H, Morin CM. 2005. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 23(25):6083–6096.
  • Sheely LC. 1996. Sleep disturbances in hospitalized patients with cancer. Oncol Nurs Forum. 23(1):109–111.
  • Soucise A, Vaughn C, Thompson CL, Millen AE, Freudenheim JL, Wactawski-Wende J, Phipps AI, Hale L, Qi L, Ochs-Balcom HM. 2017. Sleep quality, duration, and breast cancer aggressiveness. Breast Cancer Res Treat. 164(1):169–178.
  • Sultan A, Choudhary V, Parganiha A. 2014. Circadian rhythms in physical activity and energy expenditure in cancer patients. SAJEB. 4(6):327–337.
  • Sultan A, Choudhary V, Parganiha A. 2017a. Monitoring of rest-activity rhythm in cancer patients paves the way for the adoption of patient-specific chronotherapeutic approach. Biol Rhythm Res. 48(2):189–205.
  • Sultan A, Choudhary V, Parganiha A. 2017b. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles. Chronobiol Int. 34(5):609–623.
  • Sultan A, Pati AK, Choudhary V, Parganiha A. 2018. Hospitalization-induced exacerbation of the ill effects of chemotherapy on rest-activity rhythm and quality of life of breast cancer patients: a prospective and comparative cross-sectional follow-up study. Chronobiol Int. 35(11):1513–1532.
  • Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, Tamblyn R. 2017. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat. 165(2):229–245.
  • Taylor TR, Huntley ED, Makambi K, Sween J, Adams-Campbell LL, Frederick W, Mellman TA. 2012. Understanding sleep disturbances in African-American breast cancer survivors: a pilot study. Psychooncology. 21(18):896–902.
  • Tembo AC, Parker V. 2009. Factors that impact on sleep in intensive care patients. Intensive Crit Care Nurs. 25(6):314–322.
  • Thompson CL, Li L. 2012. Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat. 134(3):1291–1295.
  • Topf M. 1992. Effects of personal control over hospital noise on sleep. Res Nurs Health. 15(1):19–28.
  • Topf M, Davis J. 1993. Critical care unit noise and rapid eye movement (REM) sleep. Heart Lung. 22(3):252–258.
  • Van-Onselen C, Cooper BA, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Paul S, Miaskowski C. 2012. Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance. Support Care Cancer. 20(10):2611–2619.
  • Wright CE, Bovbjerg DH, Montgomery GH, Weltz C, Goldfarb A, Pace B, Silverstein JH. 2009. Disrupted sleep the night before breast surgery is associated with increased postoperative pain. J Pain Symptom Manage. 37(3):352–362.
  • Yao C, Bernstein LJ, Rich JB. 2017. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review. Breast Cancer Res Treat. 166(1):15–28.
  • Yoon J, Malin JL, Tao ML, Tisnado DM, Adams JL, Timmer MJ, Ganz PA, Kahn KL. 2008. Symptoms after breast cancer treatment: are they influenced by patient characteristics? Breast Cancer Res Treat. 108(2):153–165.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.